MedSec, a provider of medical device security, is establishing a new healthcare technology cyber-risk management team to expand its biomedical and clinical capabilities. Phil Englert, who is currently MedSec’s chief product officer and a healthcare technology cyber-risk management expert, will move to the role of advisor to the new team.
“MedSec serves stakeholders of all kinds within the medical device eco-system. The establishment of this team allows us to better serve our hospital clients, who are tackling medical device security on a day-to-day basis,” says Justine Bone, the company’s CEO
MedSec takes a technology first approach at helping clients understand and prioritize what matters most as threats to this critical infrastructure continue to increase.
“Biomedical and clinical engineering teams already have too many things on their plate—and they need leverage. Becoming an extension of their team, augmented by our technology capabilities, we’re able to help our customers do things that they would otherwise not be capable of doing with their existing staff,” says Andrew Donarumo, chief technology officer at MedSec. “Our clients love the combination of being able to ‘speak tech’ but also ‘understand clinical’ to help them further achieve their goals.”
As advisor, Englert will continue to help MedSec develop security solutions for hospitals. Englert brings deep knowledge of clinical settings and medical technology to the role. His career spans over 30 years of technical and operational leadership in the healthcare and life sciences space focused on strategic direction setting, operations improvement, and data and technology- enabled business optimization and transformation initiatives.
